Search

everythinglearnresearchcommunity

for

Search:↓

Understanding and tracking our body's natural daily rhythms could help improve heart health.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Electrospun 3D nanofibrous materials show promise for bone regeneration in orthopaedics.

Certain gene variations may increase the risk of hair loss in Egyptians.

An elderly Chinese man lost all his hair after taking a new heart medication.

Food-derived peptides may help prevent diseases like high blood pressure and high cholesterol, and can support the immune system.

Sarcoidosis can mimic other skin disorders, making diagnosis challenging.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

A(1-7) treatment reduces symptoms of lupus in mice.

Some blood pressure medications are linked to a higher risk of skin cancer.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

A 32-year-old woman's hair loss was linked to skin nodules and severe headaches.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Spironolactone might lower the chance of getting rosacea.

A woman with anorexia developed gout from self-induced vomiting.

Hair loss doesn't affect COVID-19 severity.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.